Determination of cisplatin and its hydrolytic metabolite in human serum by capillary electrophoresis techniques

被引:55
作者
Huang, Z
Timerbaev, AR
Keppler, BK
Hirokawa, T
机构
[1] Hiroshima Univ, Dept Appl Chem, Grad Sch Engn, Higashihiroshima 7398527, Japan
[2] Univ Vienna, Inst Inorgan Chem Bioinorgan Environm & Radiochem, A-1090 Vienna, Austria
[3] Russian Acad Sci, Vernadsky Inst Geochem & Analyt Chem, Moscow 119991, Russia
关键词
platinum anticancer drugs; human serum; micellar electrokinetic chromatography; capillary zone electrophoresis; transient isotachophoresis;
D O I
10.1016/j.chroma.2005.09.042
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Cisplatin is for a long time in clinical use as efficient antitumor drug. The success in cisplatin-based chemotherapy, however, strongly depends on how careful the drug's dosages are monitored in order to reduce severe side-effects and overcome cellular resistance. The use of micellar electrokinetic chromatography with direct UV detection is described for the determination of intact cisplatin in human serum. The main product of drug's hydrolytic metabolism, cis-diammineaquachloroplatinum(II), was quantified using capillary zone electrophoresis in combination with indirect UV detection and on-line transient isotachophoresis preconcentration. The detection limits of platinum species studied were about 2-3 mu mol l(-1) that allows the proposed methods to be applied for quantification of the administered levels of cisplatin as well as drug's active metabolite. Chan es in the speciation of cisplatin occurring after intravenous administration can also be monitored using these simple and convenient CE techniques. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:75 / 79
页数:5
相关论文
共 26 条
  • [1] Speciation of platinum compounds: a review of recent applications in studies of platinum anticancer drugs
    Barefoot, RR
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2001, 751 (02): : 205 - 211
  • [2] On-line preconcentration strategies for trace analysis of metabolites by capillary electrophoresis
    Britz-McKibbin, P
    Terabe, S
    [J]. JOURNAL OF CHROMATOGRAPHY A, 2003, 1000 (1-2) : 917 - 934
  • [3] Conventional and chromatographic ICPMS analysis of cisplatin and carboplatin in plasma and plasma ultrafiltrate
    Burns, RB
    Gray, DJ
    [J]. PLASMA SOURCE MASS SPECTROMETRY: APPLICATIONS AND EMERGING TECHNOLOGIES, 2003, : 74 - 81
  • [4] Recent developments in the field of tumor-inhibiting metal complexes
    Galanski, M
    Arion, VB
    Jakupec, MA
    Keppler, BK
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (25) : 2078 - 2089
  • [5] Uptake of antitumor platinum(II)-complexes by cancer cells, assayed by inductively coupled plasma mass spectrometry (ICP-MS)
    Ghezzi, A
    Aceto, M
    Cassino, C
    Gabano, E
    Osella, D
    [J]. JOURNAL OF INORGANIC BIOCHEMISTRY, 2004, 98 (01) : 73 - 78
  • [6] Novel separation method for highly sensitive speciation of cancerostatic platinum compounds by HPLC-ICP-MS
    Hann, S
    Stefánka, Z
    Lenz, K
    Stingeder, G
    [J]. ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2005, 381 (02) : 405 - 412
  • [7] Application of HPLC-ICP-MS to speciation of cisplatin and its degradation products in water containing different chloride concentrations and in human urine
    Hann, S
    Koellensperger, G
    Stefánka, Z
    Stingeder, G
    Fürhacker, M
    Buchberger, W
    Mader, RM
    [J]. JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY, 2003, 18 (11) : 1391 - 1395
  • [8] Capillary electrophoresis in anti-cancer metallodrug research: Advances and future challenges
    Hartinger, CG
    Timerbaev, AR
    Keppler, BK
    [J]. ELECTROPHORESIS, 2003, 24 (12-13) : 2023 - 2037
  • [9] Liquid chromatographic determination of cis-platin as platinum(II) in pharmaceutical preparation, serum and urine samples of cancer patients
    Khuhawar, MY
    Arain, GM
    [J]. TALANTA, 2005, 66 (01) : 34 - 39
  • [10] On-line sample preconcentration techniques in micellar electrokinetic chromatography
    Kim, JB
    Terabe, S
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2003, 30 (06) : 1625 - 1643